Discover award-winning AI at ECR 2024
Discover award-winning AI at ECR 2024
Annalise Enterprise CTB

Cutting edge decision-support AI for non-contrast head CT studies.

Annalise Enterprise CTB

The evolution of comprehensive decision-support AI for non-contrast head CT studies.

Annalise Triage for non-contrast head CT studies

Annalise Triage is U.S. FDA (Food and Drug Administration) cleared for the triage and notification of 7 findings, the most comprehensive list of findings on non-contrast head CT studies.

Some features are not available in all regions, please check the regulatory status with an Annalise.ai employee.

Annalise Triage has received a 510(K) clearance from the U.S. Food and Drug Administration (FDA) for use in triage on non-contrast head CT studies. Annalise Triage uses deep learning to identify the suspected presence of time-sensitive pathologies and flag priority cases within the radiology worklist, assisting the care team in treating patients with the most critical conditions first. Findings include acute subdural/epidural hematoma, acute subarachnoid hemorrhage, intra-axial hemorrhage and intraventricular hemorrhage, obstructive hydrocephalus, vasogenic edema and mass effect.

Designed to be an assistive workflow tool, Annalise Triage assists clinicians to make accurate and fast decisions when every second counts.

High-precision tool for prioritization.

Triaging specific subtypes of brain hemorrhage is
important

Because each type has its own specific causes, symptoms, and treatments. The 510(k) cleared findings for use in triage and notification for CTB are:

  • Acute subdural/epidural hematoma
  • Acute subarachnoid hemorrhage
  • Intra-axial hemorrhage
  • Intraventricular hemorrhage

Improve diagnostic accuracy and decision making

Annalise Enterprise CTB is like a ‘second pair of eyes’ for radiologists, empowering them to make accurate decisions.

It can detect up to 130 radiological findings on non-contrast CT Brain (NCCTB) studies, including a wide range of conditions that require rapid intervention.

 

Improves diagnostic accuracy by 32%, averaged across all 130 findings.


After 6 weeks of use, 9 out of 10 clinicians said Annalise Enterprise CTB improved reporting accuracy.

 

“If the CT Brain Module hadn’t picked up the superior sagittal sinus tear, [the onsite clinical team] would not have known the thrombosis existed.”

 

Dr Peter Brotchie, Associate Professor, St. Vincent’s Hospital Melbourne

Annalise Enterprise CTB

Detect up to 130 findings

on non-contrast CT Brain (NCCTB) studies.

The algorithm can identify up to 130 radiological findings, including a wide range of conditions that require time sensitive interventions. Annalise Enterprise CTB is designed to be an assistive clinical tool, empowering radiologists with a ‘second pair of eyes’ to then make accurate and fast decisions when every second counts.


 

“As humans, we can be susceptible to cognitive biases that affect how we look at images, whereas software will look at things objectively every time, so you get a slightly different perspective.”

 

Dr Dobb, Consultant in Acute Medicine, Emergency Department, NHS Grampian

Annalise Enterprise CTB

Work faster and smarter.

Our solution can free up radiologists’ time, with 60% of clinicians saying they are faster using Annalise Enterprise CT Brain.

  • Results available in under 2 minutes.
  • 11% efficiency improvement, averaged across all 130 findings.

“It’s really helpful when you get tired. I use it to double check if I’ve missed something and it highlights findings on the image very nicely. It’s like a chaperone that improves my reporting, I absolutely love it.”

Professor Dr Jens Froelich, I-TeleRAD

Work faster and smarter.

Our solution can free up radiologists’ time, with 60% of clinicians saying they are faster using Annalise Enterprise CT Brain.

  • Results available in under 2 minutes.
  • 11% efficiency improvement across all 130 findings.

“Care providers increasingly prefer solutions that can detect multiple anomalies in a single scan, which can reduce image reading time and minimize human error.”

Frost & Sullivan, Top Artificial Intelligence Trends Influencing the Future of Radiology, 11 Aug 22

Advanced technology for better patient outcomes.

Position yourself at the forefront of care with our state-of-the-art solution.

“The CT Brain solution significantly impacted patient management.”

Dr Peter Brotchie, Associate Professor, St. Vincent’s Hospital Melbourne

Advanced technology for better patient outcomes.

Position yourself at the forefront of care with our state-of-the-art solution.

“…missed diagnoses or misdiagnoses can be reduced enabling patients to be treated sooner and outcomes to be improved.”

Signify Premium Insight: Annalise hoping to get comprehensively

Intuitive design

By clinicians, for clinicians.

The Annalise Viewer automatically highlights the suspected location of findings on multiplanar reformatted images with pathology-appropriate window and level settings.

Results available in less than 2 minutes.

Intuitively designed

By clinicians, for clinicians.

The Annalise Viewer automatically highlights the suspected location of findings on multiplanar reformatted images with pathology-appropriate window and level settings.

Prioritise your worklist

Reduce time to action critical findings.

Annalise Enterprise’s AI models are designed to analyse studies in a RIS/PACS system. They  are able to prioritise cases in your site’s reporting worklist, according to your preferences, enabling radiologists to triage cases effectively and complete time-critical reports first.

Worklist prioritisation.

Designed to reduce time to action critical findings.

Annalise Enterprise’s AI models analyse studies immediately and provide a notification of urgent cases in your site’s reporting worklist. With the comprehensive number of findings and integration with your PACS, RIS or Reporting Worklist system, radiologists can more efficiently prioritise their work and report on the cases they deem most urgent first.

Worklist prioritization.

Designed to reduce time to action critical findings.

Annalise Enterprise’s AI models analyze studies immediately and provide a notification of urgent cases in your site’s reporting worklist. With the comprehensive number of findings and integration with your PACS, RIS or Reporting Worklist system, radiologists can more efficiently prioritize their work and report on the cases they deem most urgent first.

Intuitively designed

By clinicians, for clinicians.

The Annalise Viewer assists clinicians with image prioritization, alleviating concerns about disruptions and distractions hindering their workflow.

Powered by clinically robust AI

The size, quality and diversity of training data enabled us to develop a high-performing and generalisable AI model.

229,000+

unique CTB studies

Annalise Enterprise CTB’s AI algorithm was trained on over 229,000 unique non-contrast CTB studies.

140+

consultant radiologists

At least three radiologists with access to future and past context (including MRI imaging and clinical reports) and trained in standardised annotating procedures hand-annotated all the studies.

269,000,000+

CTB labels

All annotations were generated by fully qualified radiologists to train the AI model.

269,000,000+

CTB labels

All annotations were generated by fully qualified radiologists to train the AI model.

269,000,000+

CTB labels

All annotations were generated by fully qualified radiologists in order to train the AI model.  All FDA-cleared Annalise CTB findings are a subset of a comprehensive group of findings, validated and available for clinical use outside the U.S., with clinical studies showing improvements in detection accuracy, diagnostic decision-making, and reporting speed.

Annalise Enterprise is intended to assist radiologists with the interpretation of radiological imaging studies. Annalise Enterprise is not available for purchase by the general public.

Annalise Enterprise CTB is available for clinical use in Australia, New Zealand, EU, UK, India, ASEAN*, Singapore UAE, more and growing.

Annalise Enterprise CTB is CE marked under Regulation (EU) 2017/745 as a class IIb medical device.

For detailed device information, including indications for use, contraindications, and warnings, please consult the user guide prior to use.

Not all features are available in all regions. Annalise Enterprise CTB is not for sale in the U.S.

Annalise.ai, ANNALISE ENTERPRISE and the Annalise logo are trademarks of Annalise-AI Pty Ltd, registered in Australia and other countries and regions.

*Annalise Enterprise CTB is not available in all ASEAN countries.

Please reach out to Annalise.ai directly for further information.

Annalise Enterprise is intended to assist radiologists with the interpretation of radiological imaging studies. Annalise Enterprise is not available for purchase by the general public.

Annalise Enterprise CTB is available for clinical use in Australia, New Zealand, EU, UK, India, ASEAN*, Singapore UAE, more and growing.

Annalise Enterprise CXR is CE marked under Regulation (EU) 2017/745 as a class IIb medical device.

For detailed device information, including indications for use, contraindications, and warnings, please consult the user guide prior to use.

Not all features are available in all regions. Annalise Enterprise CTB is not for sale in the U.S.

Annalise.ai, ANNALISE ENTERPRISE and the Annalise logo are trademarks of Annalise-AI Pty Ltd, registered in Australia and other countries and regions.

*Annalise Enterprise CTB is not available in all ASEAN countries.

Please reach out to Annalise.ai directly for further information.

All FDA-cleared Annalise CTB findings are a subset of a comprehensive group of findings, validated and available for clinical use outside the U.S., with clinical studies showing improvements in detection accuracy, diagnostic decision-making, and reporting speed. See the Evidence.

Annalise Enterprise is not available for purchase by the general public. Always follow the directions for use.

Not all features are available in all regions, please reach out to Annalise.ai directly for further information.

Drafting the future of radiology with
Annalise Reporting!

Annalise Enterprise CTB  is now available with our automated draft reporting feature.

Designed to make radiology reporting quick and easy, Annalise Reporting creates complete editable draft reports ready for radiologists to review and sign off.

Annalise Reporting is fully integrated into the routine reporting workflow and backed by the comprehensive set of findings built into Annalise solutions.

Drafting the future of radiology with
Annalise Reporting!

Annalise Enterprise CTB  is now available with our automated draft reporting feature.

Designed to make radiology reporting quick and easy, Annalise Reporting creates complete editable draft reports ready for radiologists to review and sign off.

Annalise Reporting is fully integrated into the routine reporting workflow and backed by the comprehensive set of findings built into Annalise solutions.

Discover Annalise Solutions

Contact us to request a brochure, private demonstration, or to ask any questions you may have.


Warning: Undefined array key "country_code" in /www/annalise_914/public/wp-content/themes/annalise/footer.php on line 154